Qiyu Fang

623 total citations
22 papers, 438 citations indexed

About

Qiyu Fang is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Qiyu Fang has authored 22 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 10 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Qiyu Fang's work include Cancer Genomics and Diagnostics (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Qiyu Fang is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Qiyu Fang collaborates with scholars based in China, United States and Taiwan. Qiyu Fang's co-authors include Yanping Wan, Renying Xu, Wei Lu, Wei Cai, Yayi He, Qinfang Deng, Wencheng Zhao, Minlin Jiang, Jia Yu and Zixuan Zheng and has published in prestigious journals such as Advanced Functional Materials, ACS Applied Materials & Interfaces and Seminars in Cancer Biology.

In The Last Decade

Qiyu Fang

21 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiyu Fang China 11 228 122 100 98 89 22 438
Judong Luo China 11 256 1.1× 126 1.0× 82 0.8× 90 0.9× 63 0.7× 21 450
Vasiliki Lygirou Greece 14 241 1.1× 58 0.5× 93 0.9× 75 0.8× 49 0.6× 29 451
Huimin Ma China 11 159 0.7× 79 0.6× 95 0.9× 61 0.6× 81 0.9× 44 389
Qikuan He China 12 199 0.9× 66 0.5× 79 0.8× 59 0.6× 98 1.1× 20 415
Yuwen Xie China 12 268 1.2× 62 0.5× 115 1.1× 100 1.0× 39 0.4× 26 443
Yonggang He China 16 228 1.0× 134 1.1× 157 1.6× 119 1.2× 39 0.4× 44 503
Eszter Csánky Hungary 11 268 1.2× 44 0.4× 106 1.1× 82 0.8× 34 0.4× 29 459
Deyu Li China 9 231 1.0× 85 0.7× 138 1.4× 139 1.4× 33 0.4× 35 580
Koichi Saruwatari Japan 12 333 1.5× 342 2.8× 110 1.1× 212 2.2× 69 0.8× 38 694

Countries citing papers authored by Qiyu Fang

Since Specialization
Citations

This map shows the geographic impact of Qiyu Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiyu Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiyu Fang more than expected).

Fields of papers citing papers by Qiyu Fang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiyu Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiyu Fang. The network helps show where Qiyu Fang may publish in the future.

Co-authorship network of co-authors of Qiyu Fang

This figure shows the co-authorship network connecting the top 25 collaborators of Qiyu Fang. A scholar is included among the top collaborators of Qiyu Fang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiyu Fang. Qiyu Fang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xiaozhen, Shiqi Mao, Chuchu Shao, et al.. (2025). BIRC5 expression correlates with immunosuppressive phenotype and predicts inferior response to immunotherapy in lung adenocarcinoma. Journal of Thoracic Disease. 17(8). 5921–5935.
3.
Bo, Bing, Wei Li, Jiayu Li, et al.. (2023). Programmable DNA Circuit-Facilitated Determination of Circulating Extracellular Vesicle PD-L1 for Lung Cancer Diagnosis and Immunotherapy Response Prediction. ACS Applied Materials & Interfaces. 15(14). 17696–17704. 8 indexed citations
4.
Fang, Qiyu, Hui Sun, Yixue Li, et al.. (2023). Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer. Frontiers in Oncology. 13. 1116809–1116809. 3 indexed citations
5.
Deng, Qinfang, Chao Li, Jing Liu, et al.. (2023). DNMT3A governs tyrosine kinase inhibitors responses through IAPs and in a cell senescence-dependent manner in non-small cell lung cancer.. PubMed. 13(8). 3517–3530. 7 indexed citations
7.
Fang, Qiyu, Jia Yu, Wei Li, et al.. (2022). Prognostic value of inflammatory and nutritional indexes among advanced NSCLC patients receiving PD‐1 inhibitor therapy. Clinical and Experimental Pharmacology and Physiology. 50(2). 178–190. 27 indexed citations
8.
Wang, Hao, Haoyue Guo, Chenglong Sun, et al.. (2021). Single-Cell Sequencing, an Advanced Technology in Lung Cancer Research. OncoTargets and Therapy. Volume 14. 1895–1909. 10 indexed citations
9.
Wang, Hao, Shanhao Chen, Chunyan Wu, et al.. (2021). Tumor Mutation Burden and Differentially Mutated Genes Among Immune Phenotypes in Patients with Lung Adenocarcinoma. OncoTargets and Therapy. Volume 14. 2953–2965. 9 indexed citations
10.
Guo, Haoyue, Lishu Zhao, Junjie Zhu, et al.. (2021). Microbes in lung cancer initiation, treatment, and outcome: Boon or bane?. Seminars in Cancer Biology. 86(Pt 2). 1190–1206. 30 indexed citations
11.
Guo, Haoyue, Li Diao, Xiaofeng Zhou, et al.. (2021). Artificial intelligence-based analysis for immunohistochemistry staining of immune checkpoints to predict resected non-small cell lung cancer survival and relapse. Translational Lung Cancer Research. 10(6). 2452–2474. 19 indexed citations
12.
Zhu, Liang, Minlin Jiang, Hao Wang, et al.. (2021). A narrative review of tumor heterogeneity and challenges to tumor drug therapy. Annals of Translational Medicine. 9(16). 1351–1351. 85 indexed citations
13.
Jiang, Minlin, Hao Xu, Yang Li, et al.. (2021). Risk-score model to predict prognosis of malignant airway obstruction after interventional bronchoscopy. Translational Lung Cancer Research. 10(7). 3173–3190. 5 indexed citations
14.
Deng, Qinfang, Qiyu Fang, Hui Sun, et al.. (2020). Detection of plasmaEGFRmutations for personalized treatment of lung cancer patients without pathologic diagnosis. Cancer Medicine. 9(6). 2085–2095. 12 indexed citations
15.
Deng, Qinfang, et al.. (2020). Cyclooxygenase-2 mediates gefitinib resistance in non-small cell lung cancer through the EGFR/PI3K/AKT axis. Journal of Cancer. 11(12). 3667–3674. 16 indexed citations
16.
17.
Yu, Jia, Qiyu Fang, & Shuyan Meng. (2018). Knockdown of Long Noncoding RNA ENST457720 Inhibits Proliferation of Non-Small Cell Lung Cancer Cells In Vitro and In Vivo. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 27(1). 47–53. 10 indexed citations
18.
Deng, Qinfang, Leilei Wu, Chao Li, et al.. (2018). Competitive evolution of NSCLC tumor clones and the drug resistance mechanism of first-generation EGFR-TKIs in Chinese NSCLC patients. Heliyon. 4(12). e01031–e01031. 11 indexed citations
19.
Xu, Renying, Yanping Wan, Qiyu Fang, Wei Lu, & Wei Cai. (2011). Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model. Journal of Clinical Biochemistry and Nutrition. 50(1). 72–77. 101 indexed citations
20.
Fang, Qiyu, et al.. (2009). [Comparison of different definitions on metabolic syndrome in obese children].. PubMed. 30(12). 1297–301. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026